Journal of Antimicrobial Chemotherapy

Article	Citations
Correction to: Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomon	126
Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching—authors’ response	94
Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy	89
Epidemiology and clinical relevance of persistent bacteraemia in patients with Gram-negative bloodstream infection: a retrospective cohort study	84
Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches	83
Meropenem concentrations in brain tissue of neurointensive care patients exceed CSF levels	71
Evaluation of the RESIST ACINETO multiplex immunochromatographic assay for detection of OXA-23-like, OXA-40/58-like and NDM carbapenemase production in Acinetobacter baumannii	68
Establishment of epidemiological cut-off values of etimicin: a new fourth-generation aminoglycoside, against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudom	57
Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco	55
NDM-5-producing Klebsiella pneumoniae ST258 in a university hospital in Argentina	54
Comment on: A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections	54
Correlation between rrs gene mutations and amikacin resistance in Mycobacterium abscessus: implications for fitness cost and clinical prevalence	51
Correction to: Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species	50
Genomic analyses of Staphylococcus aureus isolated from yaks in Ganzi Tibetan Autonomous Prefecture, China	48
Overcoming antimicrobial resistance in Helicobacter pylori: the roles of collateral sensitivity and biofilm dynamics	47
Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads	46
Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant Aspergillus fumigatus with multiple CYP51A mutations	46
A novel Bacteroides metallo-β-lactamase (MBL) and its gene (crxA) in Bacteroides xylanisolvens revealed by genomic sequencing and functional analysis	45
Uropathogenic Escherichia coli population structure and antimicrobial susceptibility in Norfolk, UK	44
Emergence of the mobile RND-type efflux pump gene cluster tmexCD1-toprJ1 in Klebsiella pneumoniae clinical isolates in Japan	43
General practice antibiotic prescriptions attributable to respiratory syncytial virus by age and antibiotic class: an ecological analysis of the English population	42
Distinct molecular epidemiology of resistances to extended-spectrum cephalosporins and carbapenems in Enterobacter hormaechei in cats and dogs versus horses in France	41
Off-label use of dalbavancin in children: a case series	40
Transmission barrier of the blaKPC plasmid mediated by type I restriction-modification systems in Escherichia coli	40
Inhibition of d-alanylation of teichoic acids overcomes resistance of methicillin-resistant Staphylococcus aureus	40

A drug candidate for Alzheimer’s and Huntington’s disease, PBT2, can be repurposed to render Neisseria gonorrhoeae susceptible to natural cationic antimicrobial peptides	39
Development and application of Cas13a-based diagnostic assay forNeisseria gonorrhoeaedetection and azithromycin resistance identification	37
SQ31f is a potent non-tuberculous mycobacteria antibiotic by specifically targeting the mycobacterial F-ATP synthase	37
Specific mutations in the HIV-1 G-tract of the 3′-polypurine tract cause resistance to integrase strand transfer inhibitors	37
Genomic and transcriptomic variation in Bordetella spp. following induction of erythromycin resistance	37
Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient	37
Prosthetic joint infections: 6 weeks of oral antibiotics results in a low failure rate	37
Population pharmacokinetics of flucloxacillin as intermittent bolus infusion in patients with Staphylococcus aureus bloodstream infection	36
Phenotypic and genotypic antimicrobial susceptibility patterns of the emerging human respiratory pathogen Mycoplasma amphoriforme isolated from the UK and Denmark	35
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study	34
Model-based translation of results from in vitro to in vivo experiments for afabicin activity against Staphylococcus aureus	34
Liposomal amikacin and Mycobacterium abscessus: intimate interactions inside eukaryotic cells	34
The impact of palliative care consultation on reducing antibiotic overuse in hospitalized patients with terminal cancer at the end of life: a propensity score-weighting study	34
Antibacterial activity of propylene glycol against Staphylococcus aureus and Staphylococcus epidermidis in neutral and mild acidic conditions	33
Antimony used as rescue therapy in a kidney transplant recipient unresponsive to liposomal amphotericin B for chronic visceral leishmaniasis	33
Mitigation of benznidazole toxicity and oxidative stress following ascorbic acid supplementation in an adult traveller with chronic indeterminate Chagas’ disease	32
Ultra-rapid selection of the N74D capsid inhibitor resistance mutation after 3 weeks on lenacapavir	32
Indolocarbazoles as host-directed therapeutics against intracellular infections by methicillin-resistant Staphylococcus aureus	31
Engineering a CRISPR interference system targeting AcrAB-TolC efflux pump to prevent multidrug resistance development in Escherichia coli	31
Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis	31
Point-of-care tests to manage acute respiratory tract infections in primary care: a systematic review and qualitative synthesis of healthcare professional and patient views	30
Correction to: Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV	30
Conventional versus extended-pulsed fidaxomicin dosing in patients at high risk of recurrence ofClostridioides difficileinfection: a propensity score analysis	30
Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?	30
Systematic review on oral antibacterial relay therapy for acute staphylococcal prosthetic joint infections treated with debridement, antibiotics and implant retention (DAIR)	30
Liver cyst penetration of antibiotics at the target site of infection: a randomized pharmacokinetic trial	29
Plasma concentration of orally administered amoxicillin and clindamycin in patients receiving haemodialysis	28
Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016–20	28
Effect of empiric antibiotics against Pseudomonas aeruginosa on mortality in hospitalized patients: a systematic review and meta-analysis—authors’ response	28
Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae	28
Oral antimicrobial agents in patients with short bowel syndrome: worth a try!—authors’ response	28
Antibiotic biocompatibility assay and anti-biofilm strategies for Pseudomonas aeruginosa infection in bioengineered artificial skin substitutes	28
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study	27
Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children	27
Syndromic diagnostic testing: a new way to approach patient care in the treatment of infectious diseases	27
Comment on: Community-acquired pneumonia: a US perspective on the guideline gap	26
Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus: from in vitro time–kill experiments to a mouse pneumonia mod	26
Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre inf	26
Population pharmacokinetics of cefazolin in maternal and umbilical cord plasma, and simulated exposure in term neonates	26
Plasmodium falciparum isolates: ex vivo drug response	26
Plasma protein binding of ceftriaxone in critically ill patients: can we predict unbound fractions?	26
Striking differences in weight gain after cART initiation depending on early or advanced presentation: results from the ANRS CO4 FHDH cohort	26
Implementation of the EUCAST rapid antimicrobial susceptibility test (RAST) directly from positive blood culture bottles without the advanced identification systems	25
Influence of tedizolid on the cytokine response to the endotoxin challenge in healthy volunteers: a cross-over trial	25
Comparison of different biomass methodologies to adjust sales data on veterinary antimicrobials in the USA	25
Leveraging interdisciplinary management in people with HIV and lymphoid neoplasms	24
Selection and characterization of mutational resistance to aztreonam/avibactam in β-lactamase-producing Enterobacterales	24
Pharmacokinetics and placental transfer of dolutegravir in pregnancy	24
Effect of sigma E on carbapenem resistance in OXA-48-producing Klebsiella pneumoniae	24
Effect of different strategies for excluding duplicate cultures on the correlation between hospital resistance rates and antibiotic consumption	24

Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a mul	23
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginos	23
Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022	23
Reporting England’s progress towards the ambitions in the UK action plan for antimicrobial resistance: the English surveillance programme for antimicrobial utilisation and resistance (ESPAUR)	23
In vivo efficacy of WCK 6777 (ertapenem/zidebactam) against carbapenemase-producing Klebsiella pneumoniae in the neutropenic murine pneumonia model	22
Synergistic effects of quorum-sensing molecules and antimicrobials against Candida albicans and Pseudomonas aeruginosa biofilms: in vitro and in vivo studies	22
A systematic review of antimicrobial resistance in Neisseria gonorrhoeae and Mycoplasma genitalium in sub-Saharan Africa	22
Assessment of co-resistance to antibiotics recommended for acute pyelonephritis among Escherichia coli clinical strains from community- and nursing home–acquired urinary tract infections	22
Novel tigecycline resistance gene cluster tnfxB3-tmexCD3-toprJ1b in Proteus spp. and Pseudomonas aeruginosa, co-existing with tet(X6) on an SXT/R391 integrative and	22
Activity of fosfomycin/colistin combinations against planktonic and biofilm Gram-negative pathogens	22
Empirical use of β-lactam/β-lactamase inhibitor combinations does not increase mortality compared with cloxacillin and cefazolin in methicillin-susceptible Staphylococcus aureus bacteraemia: a	22
Characterization of a multiresistance optrA- and lsa(E)-harbouring unconventional circularizable structure in Streptococcus suis	22
Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infections	21
Effect of methenamine hippurate shortage on antibiotic prescribing for urinary tract infections in Norway—an interrupted time series analysis	21
Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions	21
Activity of mecillinam against carbapenem-resistant Enterobacterales	21
Antibiotic-induced degradation of antitoxin enhances the transcription of acetyltransferase-type toxin-antitoxin operon	21
External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories	21
Absence, loss-of-function, or inhibition of Escherichia coli AcrB does not increase expression of other efflux pump genes supporting the discovery of AcrB inhibitors as antibiotic adjuvants	21
Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance	20
Validation of the Antifungal National Antimicrobial Prescribing Survey (AF-NAPS) quality assessment tool	20
Streptococcus suisprophage lysin as a new strategy for combating streptococci-induced mastitis andStreptococcus suisinfection	20
SARS-CoV-2 coinfection with additional respiratory virus does not predict severe disease: a retrospective cohort study	20
Simulated exposures of oritavancin in in vitro pharmacodynamic models select for methicillin-resistant Staphylococcus aureus with reduced susceptibility to oritavancin but minimal cross-	20
A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa	20
The role of new carbapenem combinations in the treatment of multidrug-resistant Gram-negative infections	20
Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin Americ	20
Stability of temocillin in outpatient parenteral antimicrobial therapy: is it a real option?	20
Appropriateness of virological monitoring with long-acting injectable cabotegravir and rilpivirine	20
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011–2020	20
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review	20
Genomic analysis reveals the population structure and antimicrobial resistance of avian Pasteurella multocida in China	20
Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia	20
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study	20
Population pharmacokinetics of aciclovir and its major metabolite 9-carboxymethoxymethylguanine and safety profile of valaciclovir in early liver transplant recipients	19
Clinical, pharmacological, and qualitative characterization of drug–drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa	19
The acquisition of transferable extrachromosomal fec operon is associated with a cefiderocol MIC increase in Enterobacterales	19
Influence of ultrafiltration conditions on the measurement of unbound drug concentrations: flucloxacillin as an example	19
Pristinamycin-induced sideroblastic anaemia	19
In vitro and in vivo antibacterial activity, resistance analysis and molecular docking study of pleuromutilin derivatives against Streptococcus suis	19
Pharmacokinetic/pharmacodynamic model-based optimization of temocillin dosing strategies for the treatment of systemic infections	19
Evaluation of publication bias for 12 clinical trials of molnupiravir to treat SARS-CoV-2 infection in 13 694 patients with meta-analysis	19
Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients	19
Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV	19
Efficacy of favipiravir against influenza virus resistant to both baloxavir and neuraminidase inhibitors	19
Temocillin efficacy against AmpC β-lactamase-producing Enterobacterales: a relevant alternative to cefepime?	19
Correction to: Pharmacokinetics of anti-TB drugs in children and adolescents with drug-resistant TB: a multicentre observational study from India	19
Clinical aspects and recent advances in fungal diseases impacting human health	19
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs	19
In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR Enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases	18
Off-label oritavancin treatment outcome and molecular characterization of a vancomycin- and linezolid-resistant Enterococcus faecium causing liver abscesses	18
Surveillance of antimicrobial resistant Shiga toxin-producing E. coli O157:H7 in England, 2016–2020	18
Characterization of an MDR Lactobacillus salivarius isolate harbouring the phenicol-oxazolidinone-tetracycline resistance gene poxtA	18
Impact of veterinary antibiotics on plasmid-encoded antibiotic resistance transfer	18
Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysis	18
Usefulness of inclusion of ertapenem and temocillin screening breakpoints in the EUCAST rapid antimicrobial susceptibility testing (RAST) for rapid detection of OXA-48-producing Klebsiella pneumoni	18
Antibiotic use by clinical presentation across all healthcare providers in rural Burkina Faso: a healthcare visit exit survey	18
The association between bacteriuria and adverse pregnancy outcomes: a systematic review and meta-analysis of observational studies	18
Subcutaneously administered antibiotics: a review (addendum)	18
Interventions to improve antibiotic use among dentists: a systematic review and meta-analysis	18
Prevalence of drug resistance mutations in low-level viremia patients under antiretroviral therapy in Southwestern China: a cross-sectional study	18
Swedish multicentre study of target attainments with β-lactams in the ICU: which MIC parameter should be used?	17
Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children	17
Investigation of genomic mutations and their association with phenotypic resistance to new and repurposed drugs in Mycobacterium tuberculosis complex clinical isolates	17
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis	17
Outcomes of ceftriaxone 2 g versus 1 g daily in hospitalized patients with pneumonia: a nationwide retrospective cohort study	17
Acknowledgement of referees	17
Diagnostic uncertainties in patients with bacteraemia: impact on antibiotic prescriptions and outcome	17
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa	17
Identification of multiple transfer units and novel subtypes of tmexCD-toprJ gene clusters in clinical carbapenem-resistant Enterobacter cloacae and Klebsiella oxytoca	17
Temporal trends in antibiotic prescribing and serious and nonserious infections in children presenting to general practice: a registry-based longitudinal cohort study of 162 507 individuals	17
Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences	17
Establishment of RCPA national guidelines for selective reporting of antimicrobials: processes, challenges and measuring the impact	17
GyrB in silico mining in 27 151 global gonococcal genomes from 1928–2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and	17
Decreased cyclic-AMP caused by ATP contributes to fosfomycin heteroresistance in avian Escherichia coli	17
A multi-site, international laboratory study to assess the performance of penicillin susceptibility testing of Staphylococcus aureus	17
Comment on: Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes	17
Development and evaluation of a novel rapid immunochromatographic assay for the detection of DHA-producing Enterobacterales	17
Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015–20	17
Comparative evaluation of early treatment with ceftolozane/tazobactam versus ceftazidime/avibactam for non-COVID-19 patients with pneumonia due to multidrug-resistant Pseudomonas aeruginosa	16

The antiplasmodial activity of the carboxylic acid metabolite of piperaquine and its pharmacokinetic profiles in healthy volunteers	16
Refractory versus resistant invasive aspergillosis	16
Gepotidacin: a novel, oral, ‘first-in-class’ triazaacenaphthylene antibiotic for the treatment of uncomplicated urinary tract infections and urogenital gonorrhoea	16
Preface	16
Correction to: In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance Program	16
The primary pharmacology of ceftazidime/avibactam: in vivo translational biology and pharmacokinetics/pharmacodynamics (PK/PD)	16
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients—authors’ response	16
Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infections	16
Identification of vancomycin exposure target in neonates: how much is enough?	16
Streptococcal and enterococcal endocarditis: time for individualized antibiotherapy?—authors’ response	16
Diffusion of amoxicillin into heart valves from infective endocarditis patients	16
Synergistic effect of the novel β-lactamase inhibitor BLI-489 combined with imipenem or meropenem against diverse carbapenemase-producing carbapenem-resistant Enterobacterales	16
Efficacy of oleylphosphocholine in experimental cutaneous leishmaniasis	16
Impact of changed co-amoxiclav susceptibility testing formats on apparent resistance rates for bloodstream Escherichia coli in a long-term surveillance	16
Professor Alasdair Macintosh Geddes, 14 May 1934–9 April 2024	16
Raising awareness of antimicrobial resistance: development of an ‘antibiotic footprint calculator’	16
Efficacy of meropenem against ceftazidime–avibactam-resistant Klebsiella pneumoniae producing KPC-31, KPC-33, KPC-90, KPC-106 and KPC-114	16
Treatment of persistent focalized Q fever: time has come for an international randomized controlled trial	16
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19	16
Changing epidemiology of MRSA-CC398 in Spanish hospitals located in areas with different pig farming densities: a 2023 multicentre study	15
Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY)	15
Genomic comparison of mecC-carrying methicillin-resistant Staphylococcus aureus from hedgehogs and humans in the Netherlands	15
The pharmacokinetics/pharmacodynamics of ceftazidime/avibactam for central nervous system infections caused by carbapenem-resistant Gram-negatives: a prospective study	15
Optimal dosing of amoxicillin in obese and post-gastric bypass patients using a population pharmacokinetics-pharmacodynamics model approach	15
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa	15
Prevalence and associated factors of antibiotic exposure during pregnancy in a large French population-based study during the 2010–19 period	15
Helicobacter pylori culture positivity and antimicrobial susceptibility profiles (Vancouver, Canada)	15
Correction to: Linezolid brain penetration in neurointensive care patients	15
Broad-spectrum in vitro activity of macrophage infectivity potentiator inhibitors against Gram-negative bacteria and Leishmania major	15
Efficacy of dihydroartemisinin/piperaquine in patients with non-complicated Plasmodium falciparum malaria in Yaoundé, Cameroon	15
Treatment efficacy for rectal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials	15
Carbapenem combination therapy versus standard of care for persistent methicillin-susceptible Staphylococcus aureus bacteraemia	15
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the	15
Trends in fluoroquinolone prescribing in UK primary and secondary care between 2019 and 2023	15
Activity of rezafungin against Candida auris	15
Antibiotic prescription patterns during last days of hospitalized patients with advanced cancer: the role of palliative care consultation	15
In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions	15
Cl415, a carbapenem-resistant Acinetobacter baumannii isolate containing four AbaR4 and a new variant of AbGRI2, represents a novel global clone 2 strain	15
Is cefazolin an option for treatment of staphylococcal endogenous endophthalmitis?	15
In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin	15
Emergence of mcr-8.1 gene coexisting with blaNDM in Citrobacter werkmanii isolated from a chicken farm in China	14
In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/	14
In vitro dynamics and mechanisms of cefiderocol resistance development in wild-type, mutator and XDR Pseudomonas aeruginosa	14
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments	14
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma	14
Clinical outcomes and the impact of treatment modalities in children with carbapenem-resistant Enterobacteriaceae bloodstream infections: a retrospective cohort study from a Tertiary University Hospit	14
Do antibiotics cause mitochondrial and immune cell dysfunction? A literature review	14
Oral levofloxacin: population pharmacokinetics model and pharmacodynamics study in bone and joint infections	14
In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species	14
Towards optimizing carbapenem selection in stewardship strategies: a prospective propensity score-matched study of ertapenem versus class 2 carbapenems for empirical treatment of third-generation ceph	14
Effect of albumin substitution on pharmacokinetics of piperacillin/tazobactam in patients with severe burn injury admitted to the ICU	14
Relationship of TonB-dependent receptors with susceptibility to cefiderocol in clinical isolates of Pseudomonas aeruginosa	14
In vitro activity of ceftobiprole plus ampicillin against Enterococcus faecalis causing infective endocarditis: phenotypic and genotypic characterization	14
In vitro activity of delafloxacin against clinical levofloxacin-resistant Helicobacter pylori isolates	14
Carbapenem resistance in Enterobacterales bloodstream infections among children with cancer or post-haematopoietic stem cell transplant: a retrospective cohort study	14
JAC Supplement: ‘faster ID and AST revolution: how to improve antibiotic use in the critically ill’	14
Multiresistance gene cfr(C) in Clostridium perfringens of cattle origin from China	14
Rapid determination of ceftazidime/avibactam susceptibility of carbapenemase-producing Enterobacterales directly from blood cultures: a comparative evaluation of EUCAST disc diffusion RAST and direct	14
Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study	14
A cross-species comparison of antiretroviral penetration into lymph nodes using novel physiologically based pharmacokinetic models	14
Hospitalizations and severe complications following acute sinusitis in general practice: a registry-based cohort study	14
Antifungal use in children with acute leukaemia: state of current evidence and directions for future research	14
Strengthening antimicrobial resistance diagnostics in National Reference Laboratories across One Health in South and Southeast Asia: impact of external quality assessment and targeted follow-up	14
Cefepime–taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018–22	14
Foreword	14
HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H	14
Exploring the in situ evolution of nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli isolates	14
Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistantAcinetobacter baumanniiinfections	14
Comparison of prophylactic antibiotics for endonasal transsphenoidal surgery using a national inpatient database in Japan	14
Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model	14
Evaluation of a rapid combination disc test (RCDT) for direct phenotypic detection of extended-spectrum β-lactamase production inE. colifrom positive blood culture bottles	13
Efficacy of doxycycline versus azithromycin for the treatment of rectal chlamydia: a systematic review and meta-analysis	13
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes	13
In vitro monitoring of drug resistance emergence during stepwise induction of bedaquiline and clofazimine, alone and in combination: a phenotypic and genotypic analysis	13
Co-occurrence of multiple plasmid-borne linezolid resistance genes—optrA, cfr, poxtA2 and cfr(D) in an Enterococcus faecalis isolate from retail meat	13
Utilizing dried blood spot micro-sampling and population pharmacokinetic modelling and simulation to inform ampicillin dosing in Chinese neonates	13
Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)—authors’ response	13
Application of therapeutic drug monitoring to the treatment of bacterial central nervous system infection: a scoping review	13
Association between antimicrobial usage in livestock and antimicrobial resistance in Escherichia coli isolates from human urinary tract infections in the Netherlands, 2009–2020	13
One day in Denmark: whole-genome sequence-based analysis of Escherichia coli isolates from clinical settings	13
Depolymerase as a potent adjunct to polymyxin for targeting KL160 pandrug-resistant Acinetobacter baumannii in a murine bacteremia model	13
Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics	13
Clinicomicrobiological risk factors for infective endocarditis in viridans group streptococci bacteraemia	13
The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae: past, present and future threats to effective treatment	13
Comparison of pharmacokinetics and stability of generics of cefepime, linezolid and piperacillin/tazobactam with their respective originator drugs: an intravenous bioequivalence study in healthy volun	13
Correction to: Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani	13
Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 study	13
Influence of factors commonly known to be associated with health inequalities on antibiotic use in high-income countries: a systematic scoping review	13
Feedback of Antibiotic Prescribing in Primary Care (FAPPC) trial: results of a real-world cluster randomized controlled trial in Scotland, UK	13
No accelerated progression of subclinical atherosclerosis with integrase strand transfer inhibitors compared to non-nucleoside reverse transcriptase inhibitors	13
Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in Uganda	13
Diagnostic and antibiotic stewardship lessons: an outpatient assessment of symptomatic reflex urinalysis ordering accuracy using an electronic best-practice alert	13
Intraventricular injection of eravacycline in the treatment of carbapenem-resistant Acinetobacter baumannii meningitis: a case report	13
Correction to: Plasmid-mediated azithromycin resistance in non-typhoidal Salmonella recovered from human infections	13
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model againstKlebsiella pneumoniae—authors’ response	13